Akouos, Inc. (AKUS)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Emmanuel J. Simons
Employees:
100
645 SUMMER STREET, SUITE 200, BOSTON, MA, 02210
857-410-1818
Akouos, Inc. is developing gene therapies to restore, improve, and preserve physiologic hearing. Its lead product candidate is AK-OTOF, a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. The company was incorporated in 2016 and is based in Boston, Massachusetts.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|